TY - JOUR
T1 - Anaemia management in patients with inflammatory bowel disease
T2 - Routine practice across nine European countries
AU - Stein, Jürgen
AU - Bager, Palle
AU - Befrits, Ragnar
AU - Gasche, Christoph
AU - Gudehus, Maja
AU - Lerebours, Eric
AU - Magro, Fernando
AU - Mearin, Fermin
AU - Mitchell, Daniell
AU - Oldenburg, Bas
AU - Danese, Silvio
PY - 2013/12
Y1 - 2013/12
N2 - BACKGROUND AND OBJECTIVES: Anaemia and iron deficiency (ID) are common complications in inflammatory bowel disease (IBD). In patients undergoing iron therapy, intravenous iron supplementation is recommended in preference to oral therapy. This study evaluated routine practice in the management of IBD-associated anaemia and ID to verify implementation of international treatment guidelines. MATERIALS AND METHODS: Gastroenterologists from nine European countries (n=344) were surveyed about their last five IBD patients treated for anaemia (n=1404). Collected information included tests performed at anaemia diagnosis, haemoglobin (Hb) levels and iron status parameters, the anaemia treatment given and, if applicable, the iron administration route. RESULTS: Selection of diagnostic tests and treatment for IBD-associated anaemia varied considerably across Europe. Anaemia and iron status were mainly assessed by Hb (88%) and serum ferritin (75%). Transferrin saturation was only tested in 25% of patients. At diagnosis of anaemia, 56% presented with at least moderate anaemia (Hb
AB - BACKGROUND AND OBJECTIVES: Anaemia and iron deficiency (ID) are common complications in inflammatory bowel disease (IBD). In patients undergoing iron therapy, intravenous iron supplementation is recommended in preference to oral therapy. This study evaluated routine practice in the management of IBD-associated anaemia and ID to verify implementation of international treatment guidelines. MATERIALS AND METHODS: Gastroenterologists from nine European countries (n=344) were surveyed about their last five IBD patients treated for anaemia (n=1404). Collected information included tests performed at anaemia diagnosis, haemoglobin (Hb) levels and iron status parameters, the anaemia treatment given and, if applicable, the iron administration route. RESULTS: Selection of diagnostic tests and treatment for IBD-associated anaemia varied considerably across Europe. Anaemia and iron status were mainly assessed by Hb (88%) and serum ferritin (75%). Transferrin saturation was only tested in 25% of patients. At diagnosis of anaemia, 56% presented with at least moderate anaemia (Hb
KW - intravenous iron
KW - iron deficiency
KW - iron replacement therapy
KW - iron-deficiency anaemia
UR - http://www.scopus.com/inward/record.url?scp=84887051883&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84887051883&partnerID=8YFLogxK
U2 - 10.1097/MEG.0b013e328365ca7f
DO - 10.1097/MEG.0b013e328365ca7f
M3 - Article
C2 - 24100539
AN - SCOPUS:84887051883
VL - 25
SP - 1456
EP - 1463
JO - European Journal of Gastroenterology and Hepatology
JF - European Journal of Gastroenterology and Hepatology
SN - 0954-691X
IS - 12
ER -